Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Dec 2021 – 20 Aug 2026, limited by Axis Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 08 Dec 2021 | ₹100.00 | ₹100.00 |
| 30 Apr 2022 | ₹97.92 | ₹97.90 |
| 20 Sep 2022 | ₹102.67 | ₹101.98 |
| 10 Feb 2023 | ₹102.93 | ₹102.21 |
| 03 Jul 2023 | ₹111.74 | ₹110.61 |
| 23 Nov 2023 | ₹114.89 | ₹113.35 |
| 14 Apr 2024 | ₹130.70 | ₹128.91 |
| 04 Sep 2024 | ₹147.01 | ₹144.24 |
| 25 Jan 2025 | ₹134.90 | ₹132.18 |
| 17 Jun 2025 | ₹145.58 | ₹142.27 |
| 07 Nov 2025 | ₹150.04 | ₹145.92 |
| 30 Mar 2026 | ₹131.43 | ₹127.83 |
| 20 Aug 2026 | ₹143.45 | ₹138.71 |
| Metric | Axis · Regular NAV ₹14.54 Very High risk ★★★★☆ | Category median Index Funds · 366 funds |
|---|---|---|
| -2.65% | +5.43% | |
| +8.59% | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +7.98% | +7.40% | |
| +7.15% | — | |
| +12.34% | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 13.10% | 13.88% | |
| 0.16 | 0.25 | |
| 0.22 | 0.35 | |
| -15.92% | -16.66% | |
| Nifty 50 | — | |
| +0.69% | +0.30% | |
| 0.99 | 1.00 | |
| 101.4% | 101.3% | |
| 97.2% | 98.8% | |
| 0.48% | 0.96% | |
| ₹967.79Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 08 Dec 2021 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.